COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)

NCT04510194 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1323

Enrollment

OTHER

Sponsor class

Conditions

Covid19
SARS-CoV Infection

Interventions

DRUG: Metformin
DRUG: Placebo
DRUG: Fluvoxamine
DRUG: Ivermectin

Sponsor

University of Minnesota

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]